Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results From the Canary PASS Cohort.

Adrian J Waisman MalaretPeter ChangKehao ZhuYingye ZhengLisa F NewcombMenghan LiuJesse K McKenneyJames D BrooksPeter CarrollAtreya DashChristopher P FilsonMartin E GleaveMichael LissFrances M MartinTodd M MorganPeter S NelsonDaniel W LinAndrew A Wagner

Published in: The Journal of urology (2021)

In patients on active surveillance, the rate of definitive treatment is higher after an initial diagnosis of GG2 than GG1. Adverse pathology after RP and short-term BCR after definitive treatment were similar between GG2 and GG1.

Keyphrases

prostate cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
acute lymphoblastic leukemia
squamous cell carcinoma
type diabetes
emergency department
prognostic factors
peritoneal dialysis
radical prostatectomy
locally advanced
metabolic syndrome
skeletal muscle
tyrosine kinase